Background: Although the majority of diabetes mellitus (DM) patients diagnosed as adults have
BMI, body mass index; DBP, diastolic blood pressure, DM, diabetes mellitus; FBS, fasting blood glucose; FFA, free fatty acid; GAD, glutamic acid decarboxylase; GAD antibody-negative, patients without GAD antibody; GAD antibody-positive, patients with GAD antibody; HDL-C, high-density lipoprotein cholesterol; insulin-based, insulin based treatment including insulin treatment and the combination treatment of insulin and OHA; LDL-C, low-density lipoprotein cholesterol; OHA, oral hypoglycemic agent; SBP, systolic blood pressure; TC, total cholesterol; TG, triglyceride; WC, waist circumference. Stimulated C-peptide (ng/mL) 5.11 ± 4.52 4.87 ± 3.43 1.28 ± 1.05 2.73 ± 2.37 Data are mean ± standard deviation. Macrovascular complications include coronary heart disease, cerebrovascular disease and peripheral arterial disease. * P < 0.05 for macrovascular (-) vs. macrovascular (+) in patients without GAD antibody.
†P< 0.05 for macrovascular (-) vs. macrovascular (+) in patients with GAD antibody. ‡Analyzed by Student's T-test or by Mann-Whitney test. BMI, body mass index; DM, diabetes mellitus; FBS, fasting blood glucose; GAD, glutamic acid decaroxylase; GAD antibody-negative, patients without GAD antibody; GAD antibody-positive, patients with GAD antibody; HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol; macrovascular (-), patients without macrovascular complications; macrovascular (+), patients with macrovascular complications; TC, total cholesterol; TG, triglyceride. 참 고 문 헌 
